2nd Annual Life Science Chief Executive Officer Forum

Sustaining Organizational Growth through Strategies from Licensing, Mergers & Acquisitions to Market Access and Integration in Emerging Markets, all while Maintaining Rigorous Compliance and Increasing Shareholder Value

February 2-4, 2012 | Jacksonville, FL

 

ABOUT THE FORUM

As the dynamic within the life science industry continues to change, chief executives need to be prepared with an arsenal of tools and strategies that will enable them to succeed in this evolving marketplace. From strategic licensing opportunities to mergers and acquisitions that will bolster research and product pipelines, to the investigation of emerging markets where new and existing products have yet to make in-roads, there are many decisions that need to be made from the executive office in order to keep companies viable and to sustain growth. With the challenges faced by the industry ever compounding, it is essential that forward thinking CEOs come together to discuss and debate the opportunities that are available. The 2nd Annual Life Science Chief Executive Officer Forum will bring together Presidents and CEOs of leading Pharmaceutical, Biotechnology, Medical Device and Diagnostic companies that represent a wide spectrum of company sizes, from small-cap through to mid-cap organizations, to share synergies across the entire industry.

 

TOPICS TO INCLUDE

 

  • Keynote Panel: State of the Life Science Industry
  • Case Study Presentation: Dymedex
  • Creating Effective Internal Compliance Standards
  • Analysis of M&A Activity in the Life Science Industry
  • Large Company Merger or Acquisition and Large Company Perspective on Finding Acquisitions
  • Smaller Company Perspective on Being Acquired
  • Panel Discussion: Opportunities in Raising Capital for Life Science Corporations
  • Analyzing Government Grant Opportunities as a Tactic to Augment Operational Capital
  • Evaluating The Efficiency of an Organization’s Business Model
  • Designing Streamlined Clinical Trial Plans
  • Assessing Compliance Standards Associated With Employing Physicians
  • Utilizing Comprehensive Investor Relations to Communicate Organizational Goals and Milestones
  • Recognizing the Value of Building Strong Executive Board Relationships
  • Insight into Working in and Launching Products into Emerging Markets
  • Exploring the Benefits of Industry-Academic Collaborations
  • Analyzing Social Media’s Growing Presence within the Industry
  • Roundtable Discussion: Evaluating the Benefits of Licensing and Partnerships
  • Panel Discussion: Insights into Gaining Maximum Reimbursement for Products in the Life Science Industry
  • Analyzing the Current Government Contracts Environment
  • Developing Comprehensive Global Clinical Trials
  • Exploring Successful Tactics in Crisis Management Planning
  • Successful Product Launch Strategies

 

registernow

 

FWD to a Colleague


ADD TO CALENDAR


 

FOLLOW US ON TWITTER

 

KEY PRESENTERS TO INCLUDE

 

Maurice Ferre, MD
CEO, President & Chairman
MAKO Surgical Corp.

 

Robert Cascella
President & CEO
Hologic

 

Richard Packer
CEO
Zoll Medical

 

Erik Eglite D.P.M., J.D.
VP & Chief Compliance
Officer & Corporate Counsel

Lundbeck

 

And More...


 

registernow

 

Mailing List Sign-Up